It reduces the risk of cardiovascular events in people with type 2 diabetes
Zepbound (tirzepatide) is an FDA-approved weight loss drug used with a lower-calorie diet and increased physical activity to help with weight loss and long-term weight management in adults with: a body mass index (BMI) of 30 or higher (obesity) a BMI of 27 or higher (overweight) and a weight-related health condition, such as high blood pressure, cardiovascular disease, high cholesterol, type 2 diabetes, or obstructive sleep apnea Tirzepatide, the active ingredient in Zepbound can also lower blood sugar and help people with diabetes lose weight
Modern advancements have produced powerful tools to support this, including tirzepatide glp 1, which has demonstrated significant effects on both weight and glycemic control
While many people begin retatrutide at a similar low dose, the exact starting approach can vary based on factors like medication sensitivity, prior experience with injectable therapies, and overall tolerance